<DOC>
	<DOC>NCT00116103</DOC>
	<brief_summary>The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma</brief_title>
	<detailed_description>The purpose of this randomized, double-blind, placebo-controlled, parallel-group, multi-center designed trial is to determine the safety and efficacy of tacrolimus inhalation aerosol in subjects with persistent asthma.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Diagnosis of persistent asthma for at least 6 months Require use of betaagonists at least four times per week Diagnosis of chronic obstructive pulmonary disease (COPD)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Investigational, Therapies</keyword>
	<keyword>Asthma</keyword>
	<keyword>Antiasthmatics</keyword>
	<keyword>Antiasthmatic agents</keyword>
</DOC>